RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.
- DOI
- 10.1038/s41591-023-02494-2
- Published
- 2023 Sep
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-023-02494-2,
title = {RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.},
author = {Watts GF and Schwabe C and Scott R and Gladding PA and Sullivan D and Baker J and Clifton P and Hamilton J and Given B and Melquist S and Zhou R and Chang T and San Martin J and Gaudet D and Goldberg IJ and Knowles JW and Hegele RA and Ballantyne CM},
year = {2023},
journal = {Nature medicine},
doi = {10.1038/s41591-023-02494-2},
url = {https://doi.org/10.1038/s41591-023-02494-2}
}RIS
TY - JOUR TI - RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. AU - Watts GF AU - Schwabe C AU - Scott R AU - Gladding PA AU - Sullivan D AU - Baker J AU - Clifton P AU - Hamilton J AU - Given B AU - Melquist S AU - Zhou R AU - Chang T AU - San Martin J AU - Gaudet D AU - Goldberg IJ AU - Knowles JW AU - Hegele RA AU - Ballantyne CM PY - 2023 JO - Nature medicine DO - 10.1038/s41591-023-02494-2 UR - https://doi.org/10.1038/s41591-023-02494-2 ER -
APA
GF, W., C, S., R, S., PA, G., D, S., J, B., P, C., J, H., B, G., S, M., R, Z., T, C., J, S. M., D, G., IJ, G., JW, K., RA, H., & CM, B. (2023). RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.. Nature medicine. https://doi.org/10.1038/s41591-023-02494-2
Source records
- pubmed · retrieved 2026-09-26T23:34:52.915Z